Financial News
Crispr Therapeutics Ag (NQ: CRSP )
121.67
USD
+6.63
(+5.76%)
Official Closing Price
Updated: 4:38 PM EDT, Apr 20, 2021
Add to My Watchlist
Stories about Crispr Therapeutics Ag
Are Genomic Stocks Are The Next FANG Stocks?
December 24, 2020
From Benzinga
Where to Invest $5,000 Right Now
December 24, 2020
If you're worried another market crash is imminent, you'll want to scoop up these three stocks soon.
From Motley Fool
The 3 Best Stocks for 2021
December 24, 2020
From Motley Fool
Cramer Weighs In On Salesforce, General Motors And More
December 23, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
December 23, 2020
From Benzinga
Return On Capital Employed Overview: CRISPR Therapeutics
December 22, 2020
From Benzinga
The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes
December 22, 2020
From Benzinga
Genetics Stocks Ablaze: Editas, Crispr, Intellia Rocket; Uniqure Dives
December 21, 2020
Why Editas Medicine Stock Is Skyrocketing Today
December 21, 2020
From Motley Fool
3 Biotech Stocks That Could Explode Higher in 2021
December 21, 2020
From Motley Fool
3 Top Biotech Stocks to Buy Right Now
December 19, 2020
From Motley Fool
Megatrends To Invest In Now: 3 Best ETF Picks
December 16, 2020
From StockMarket.com
Where Will CRISPR Therapeutics Be in 10 Years?
December 15, 2020
From Motley Fool
From StockMarket.com
If You Have $1,000 and 5 Years to Wait, Buy These 2 Stocks Now
December 13, 2020
From Motley Fool
Watch Out bluebird bio, CRISPR Is on Your Heels
December 12, 2020
From Motley Fool
3 Stocks That Are Giving Their Investors Coal in Their Stockings
December 12, 2020
From Motley Fool
Five investing rules from a money manager who crushes the stock market — and his take on the best companies to own now
December 11, 2020
From MarketWatch
Is CRISPR Therapeutics Heading for $170
December 10, 2020
From Motley Fool
Why Editas Medicine Stock Is Rising for a Third Consecutive Day
December 09, 2020
From Motley Fool
The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings
December 08, 2020
From Benzinga
How You Can Profit From the Best-Managed Drugmaker on Earth
December 08, 2020
From Motley Fool
Why Editas Medicine Stock Is Soaring Today
December 07, 2020
From Motley Fool
Stocks That Hit 52-Week Highs On Monday
December 07, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For December 7, 2020
December 07, 2020
From Benzinga
Here Are The Winners Of This Year's Biggest Blood Cancer Meeting
December 07, 2020
Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace
December 06, 2020
From Benzinga
Did Google's DeepMind Just Revolutionize Medicine?
December 05, 2020
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.